User menu

Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemia

Bibliographic reference Geurts, Lucie ; Muccioli, Giulio ; Delzenne, Nathalie M. ; Cani, Patrice D.. Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemia. In: PLoS One, Vol. 8, no.2, p. e55963 [1-10] (2013)
Permanent URL
  1. JM Olefsky, AnnuRevPhysiol, 72, 219 (2010)
  2. Cani P. D., Amar J., Iglesias M. A., Poggi M., Knauf C., Bastelica D., Neyrinck A. M., Fava F., Tuohy K. M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J.-F., Gibson G. R., Casteilla L., Delzenne N. M., Alessi M. C., Burcelin R., Metabolic Endotoxemia Initiates Obesity and Insulin Resistance, 10.2337/db06-1491
  3. Bluher M., Engeli S., Kloting N., Berndt J., Fasshauer M., Batkai S., Pacher P., Schon M. R., Jordan J., Stumvoll M., Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity, 10.2337/db06-0812
  4. Engeli S., Bohnke J., Feldpausch M., Gorzelniak K., Janke J., Batkai S., Pacher P., Harvey-White J., Luft F. C., Sharma A. M., Jordan J., Activation of the Peripheral Endocannabinoid System in Human Obesity, 10.2337/diabetes.54.10.2838
  5. DM Lambert, CurrOpinClinNutrMetab Care, 10, 735 (2007)
  6. GG Muccioli, MolSystBiol, 6, 392 (2010)
  7. Di Marzo Vincenzo, Piscitelli Fabiana, Mechoulam Raphael, Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes, Diabetes - Perspectives in Drug Therapy (2011) ISBN:9783642172137 p.75-104, 10.1007/978-3-642-17214-4_4
  8. V Di Marzo, EurJEndocrinol, 161, 715 (2009)
  9. V Di Marzo, PharmacolRes, 60, 77 (2009)
  10. Di Marzo Vincenzo, The endocannabinoid system in metabolic control: a preface, 10.1016/j.beem.2008.12.005
  11. Di Marzo V., Côté M., Matias I., Lemieux I., Arsenault B. J., Cartier A., Piscitelli F., Petrosino S., Alméras N., Després J.-P., Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors, 10.1007/s00125-008-1178-6
  12. Van Gaal Luc F, Rissanen Aila M, Scheen André J, Ziegler Olivier, Rössner Stephan, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study, 10.1016/s0140-6736(05)66374-x
  13. Cota Daniela, Sandoval Darleen A., Olivieri Massimiliano, Prodi Elena, D'Alessio David A., Woods Stephen C., Seeley Randy J., Obici Silvana, Food Intake-independent Effects of CB1 Antagonism on Glucose and Lipid Metabolism, 10.1038/oby.2009.84
  14. Kunos George, Tam Joseph, The case for peripheral CB1receptor blockade in the treatment of visceral obesity and its cardiometabolic complications : Peripheral CB1receptors and diet-induced obesity, 10.1111/j.1476-5381.2011.01352.x
  15. Gary-Bobo Magali, Elachouri Ghizlane, Gallas Jean François, Janiak Philip, Marini Pietro, Ravinet-Trillou Christine, Chabbert Michèle, Cruccioli Noël, Pfersdorff Christian, Roque Claude, Arnone Michèle, Croci Tiziano, Soubrié Philippe, Oury-Donat Florence, Maffrand Jean Pierre, Scatton Bernard, Lacheretz Frederic, Le Fur Gérard, Herbert Jean Marc, Bensaid Mohammed, Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats, 10.1002/hep.21641
  16. J Liu, JBiolChem, 278, 45034 (2003)
  17. Geurts Lucie, Lazarevic Vladimir, Derrien Muriel, Everard Amandine, Van Roye Marie, Knauf Claude, Valet Philippe, Girard Myriam, Muccioli Giulio G., François Patrice, de Vos Willem M., Schrenzel Jacques, Delzenne Nathalie M., Cani Patrice D., Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue, 10.3389/fmicb.2011.00149
  18. PD Cani, PharmacolTher, 130, 202 (2011)
  19. NM Delzenne, AnnuRevNutr, 31, 15 (2011)
  20. Delzenne Nathalie M., Neyrinck Audrey M., Bäckhed Fredrik, Cani Patrice D., Targeting gut microbiota in obesity: effects of prebiotics and probiotics, 10.1038/nrendo.2011.126
  21. André Aurore, Gonthier Marie-Paule, The endocannabinoid system: Its roles in energy balance and potential as a target for obesity treatment, 10.1016/j.biocel.2010.06.002
  22. Bartelt A., Orlando P., Mele C., Ligresti A., Toedter K., Scheja L., Heeren J., Di Marzo V., Altered endocannabinoid signalling after a high-fat diet in Apoe −/− mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance, 10.1007/s00125-011-2274-6
  23. I Matias, JClinEndocrinolMetab, 91, 3171 (2006)
  24. Nogueiras R., Veyrat-Durebex C., Suchanek P. M., Klein M., Tschop J., Caldwell C., Woods S. C., Wittmann G., Watanabe M., Liposits Z., Fekete C., Reizes O., Rohner-Jeanrenaud F., Tschop M. H., Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats, 10.2337/db08-0161
  25. D Osei-Hyiaman, JClinInvest, 118, 3160 (2008)
  26. KM Starowicz, Obesity(SilverSpring), 16, 553 (2008)
  27. Song D., Bandsma R. H. J., Xiao C., Xi L., Shao W., Jin T., Lewis G. F., Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice, 10.1007/s00125-011-2082-z
  28. Ottani Alessandra, Giuliani Daniela, HU 210: A Potent Tool for Investigations of the Cannabinoid System, 10.1111/j.1527-3458.2001.tb00192.x
  29. Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson N-O, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley P J, The orphan receptor GPR55 is a novel cannabinoid receptor : GPR55, a novel cannabinoid receptor, 10.1038/sj.bjp.0707460
  30. SE O'Sullivan, BrJPharmacol, 152, 576 (2007)
  31. Cani P. D., Bibiloni R., Knauf C., Waget A., Neyrinck A. M., Delzenne N. M., Burcelin R., Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice, 10.2337/db07-1403
  32. Everard Amandine, Lazarevic Vladimir, Derrien Muriel, Girard Myriam, Muccioli Giulio G., Neyrinck Audrey M., Possemiers Sam, Van Holle Ann, François Patrice, de Vos Willem M., Delzenne Nathalie M., Schrenzel Jacques, Cani Patrice D., Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice, 10.2337/db11-0227
  33. Bosier Barbara, Muccioli Giulio G., Mertens Birgit, Sarre Sophie, Michotte Yvette, Lambert Didier M., Hermans Emmanuel, Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo, 10.1016/j.neuropharm.2012.02.003
  34. Alhouayek M., Lambert D. M., Delzenne N. M., Cani P. D., Muccioli G. G., Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation, 10.1096/fj.10-176602
  35. GG Muccioli, AnalBiochem, 373, 220 (2008)
  36. V Di Marzo, Drug DiscovToday, 13, 1026 (2008)
  37. V Di Marzo, BrJPharmacol, 154, 915 (2008)
  38. V Di Marzo, BrJPharmacol, 153, 1272 (2008)
  39. Doyle Máire E, The role of the endocannabinoid system in islet biology : , 10.1097/med.0b013e32834455a8
  40. Liu J, Zhou L, Xiong K, Godlewski G, Mukhopadhyay B, et al.. (2012) Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance Via Inhibition of Insulin Signaling and Clearance in Mice. Gastroenterology.
  41. Bermúdez-Siva Francisco Javier, Serrano Antonia, Diaz-Molina Francisco Javier, Sánchez Vera Irene, Juan-Pico Pablo, Nadal Angel, Fuentes Esther, Rodríguez de Fonseca Fernando, Activation of cannabinoid CB1 receptors induces glucose intolerance in rats, 10.1016/j.ejphar.2005.12.016
  42. Eckardt K., Sell H., Taube A., Koenen M., Platzbecker B., Cramer A., Horrighs A., Lehtonen M., Tennagels N., Eckel J., Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle, 10.1007/s00125-008-1240-4
  43. Li Chen, Bowe James E., Jones Peter M., Expression and function of cannabinoid receptors in mouse islets, 10.4161/isl.2.5.12729
  44. Juan-Picó Pablo, Fuentes Esther, Javier Bermúdez-Silva F., Javier Díaz-Molina F., Ripoll Cristina, Rodríguez de Fonseca Fernando, Nadal Angel, Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell, 10.1016/j.ceca.2005.10.005
  45. Nakata Masanori, Yada Toshihiko, Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors, 10.1016/j.regpep.2007.08.009
  46. Li Chen, Jones Peter M., Persaud Shanta J., Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas, 10.1016/j.pharmthera.2010.10.006
  47. Alhamoruni A, Wright KL, Larvin M, O'Sullivan SE, Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability : Cannabinoids and intestinal permeability, 10.1111/j.1476-5381.2011.01589.x
  48. Patsouris David, Li Ping-Ping, Thapar Divya, Chapman Justin, Olefsky Jerrold M., Neels Jaap G., Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals, 10.1016/j.cmet.2008.08.015
  49. Jeong Won-il, Osei-Hyiaman Douglas, Park Ogyi, Liu Jie, Bátkai Sándor, Mukhopadhyay Partha, Horiguchi Norio, Harvey-White Judith, Marsicano Giovanni, Lutz Beat, Gao Bin, Kunos George, Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver, 10.1016/j.cmet.2007.12.007
  50. D Osei-Hyiaman, JClinInvest, 115, 1298 (2005)
  51. Liang H., Ward W. F., PGC-1 : a key regulator of energy metabolism, 10.1152/advan.00052.2006
  52. Tedesco L., Valerio A., Dossena M., Cardile A., Ragni M., Pagano C., Pagotto U., Carruba M. O., Vettor R., Nisoli E., Cannabinoid Receptor Stimulation Impairs Mitochondrial Biogenesis in Mouse White Adipose Tissue, Muscle, and Liver: The Role of eNOS, p38 MAPK, and AMPK Pathways, 10.2337/db09-1881
  53. Cavuoto P., McAinch A.J., Hatzinikolas G., Cameron-Smith D., Wittert G.A., Effects of cannabinoid receptors on skeletal muscle oxidative pathways, 10.1016/j.mce.2006.12.038